Introduction
In this article, rather than describe the role of metal ions in normal neuronal function, have focused on abnormal neuronal conditions and the role of metal ions in causing or in preventing them i.e neurotoxic metals and metal-based therapeutics. My reason was principally to reduce the scope of the topic to manageable proportions, but metal ions seem to play an important part in neuronal cell death and a better understanding of their properties could lead to improved therapeutics. Since so many different metals ions are toxic have also chosen to concentrate on those which have a normal physiological function and which become neurotoxic when this is disturbed.
Many divalent and trivalent metal ions are neurotoxic and there are a variety of mechanisms which contribute or could contribute to cell damage. Probably of greatest importance are effects involving ion channels. Calcium channels are prime targets for blockade by divalent cations1,2, but the same channels may also transport toxic metals into the cell interior to act on intracellular targets3. Ligandgated ion channels, such as the NMDA receptor, can also act both as targets for metal ions and as transporters4,5. There is good evidence that the toxicity of certain metals such as Zn2+ for example, is absolutely dependent on transport6. The true targets therefore for these (and probably other metals) are intracellular and could in principle involve enzyme inhibition or activation, promotion of free radical formation leading to protein and membrane damage, protein modification and crosslinking etc. Knowledge of the mechanisms of metal-based toxicity should provide ideas about metal-based therapeutics for CNS disorders. The use of lithium salts in the treatment and prophylaxis of bipolar affective disorder (manic depression) remains, however, the sole example. While the detailed mechanism is not clear at this stage, the idea that lithium ions interfere with intracellular signal transduction pathways seems to have taken root7. In the same way that Zn2+ toxicity, for example, could result from inhibition of divalent metal-dependent processes in the cell, it seems probable that the therapeutic benefit of Li+ could also derive from an effect on a Mg2+-dependent enzyme7. The lack of marked selectivity of enzymes for metal ions could explain the toxicity of Li+ at higher
concentrations.
An entirely different approach to metal-based drugs also emerges from an understanding of metalbased toxicity. The growing interest in free radical-mediated cell death, in which metal-catalyzed reactions play an important role, has spawned a number of approaches to neuroprotection in response to acute injury or chronic disease. One such is the use of organomanganese complexes which catalyze the dismutation of reactive oxygen species (O2.', H202) 8 . These compounds may turn out to have utility not only in neurological disorders such as stroke, but also in protecting other tissues subject to ischaemia/reperfusion injury such as the heart. 0.1mM) , and that the mode of inhibition, unusually, was uncompetitive26. The enzyme is important in phosphoinositide signalling since it is responsible for regenerating inositol for phosphoinositide synthesis (Fig.2) .
That 
